title: [Rhabdomyolysis during treatment with rabeprazole (Pariel), a proton pump inhibitor combined with domperidone (Peridys)].
authors.forename: S
authors.initials: S
authors.lastname: Bourlon
authors.forename: G
authors.initials: G
authors.lastname: Veyrac
authors.forename: C
authors.initials: C
authors.lastname: Armand
authors.forename: O
authors.initials: O
authors.lastname: Lambert
authors.forename: M
authors.initials: M
authors.lastname: Bourin
authors.forename: P
authors.initials: P
authors.lastname: Jolliet
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D000932:Antiemetics / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects*; D004294:Domperidone / Q000009:adverse effects*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008875:Middle Aged; D009853:Omeprazole / Q000031:analogs & derivatives; D064750:Rabeprazole; D012206:Rhabdomyolysis / Q000139:chemically induced*
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D000932:Antiemetics; D001562:Benzimidazoles; D064750:Rabeprazole; D004294:Domperidone; D009853:Omeprazole